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ABSTRACT: It is generally accepted that chromatin containing the
histone H3 variant CENP-A is an epigenetic mark maintaining
centromere identity. However, the pathways leading to the forma-
tion and maintenance of centromere chromatin remain poorly char-
acterized due to diﬃculties of analysis of centromeric repeats in
native chromosomes. To address this problem, in our previous stud-
ies we generated a human artiﬁcial chromosome (HAC) whose
centromere contains a synthetic alpha-satellite (alphoid) DNA array
containing the tetracycline operator, the alphoidtetO-HAC. The pres-
ence of tetO sequences allows the speciﬁc targeting of the centro-
meric region in the HAC with diﬀerent chromatin modiﬁers fused to the tetracycline repressor. The alphoidtetO-HAC has been
extensively used to investigate protein interactions within the kinetochore and to deﬁne the epigenetic signature of centromeric
chromatin to maintain a functional kinetochore. In this study, we developed a novel synthetic HAC containing two alphoid DNA
arrays with diﬀerent targeting sequences, tetO, lacO and gal4, the alphoidhybrid-HAC. This new HAC can be used for detailed
epigenetic engineering studies because its kinetochore can be simultaneously or independently targeted by diﬀerent chromatin
modiﬁers and other fusion proteins.
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Centromeres deﬁne the site of the assembly of thekinetochore, a multiprotein complex that directs chromo-
some segregation during cell division.1 In humans, endogenous
centromeres typically form on chromosome-speciﬁc higher-
order alphoid DNA arrays, which are composed of 171 bp alpha-
satellite monomer units that are tandemly arranged in a
directional head-to-tail fashion.2 Independent of this sequence
preference, speciﬁc deposition of the centromere-speciﬁc histone
H3 variant CENP-A forms the basis for an epigenetic mainte-
nance of centromere identity.3,4 The epigenetic control of centro-
mere activity is illustrated by the inactivation of centromeres on
dicentric chromosomes5 and by the formation of rare neo-
centromeres that recruit CENP-A and assemble fully functional
kinetochore structures on nonalphoid DNA.6
Microscopic investigation of stretched kinetochore ﬁbers
revealed that blocks of CENP-A nucleosomes are interspersed
with canonical histone H3 nucleosomes that contain transcription-
associated modiﬁcations, such as H3K4me2 and H3K36me2.7−9
This special chromatin was termed “centrochromatin”7 and
suggests a functional link between the local chromatin
environment and kinetochore function.1 These observations
raise several questions about the exact nature of the chromatin
that speciﬁes kinetochore assembly and propagation. (1) What
combination of histone modiﬁcations deﬁnes the elusive
epigenetic state that is centrochromatin? (2) Can histone modi-
ﬁcations be manipulated to turn normal chromatin into centro-
chromatin or, inversely, to inactivate established centromeres?
(3) What barriers prevent heterochromatin spreading into
centromeres? Answering these questions with native human
chromosomes is extremely challenging.
Knowledge of the structure and function of human centro-
meres has dramatically increased since the ﬁrst reconstitution of
functional human centromeres, when DNA satellite repeats were
transfected into human cells, forming the ﬁrst human artiﬁcial
chromosomes (HACs).10,11 Subsequently, many HACs have
been constructed using diﬀerent strategies of satellite DNA
cloning and delivery into human cells12−23
The development of RCA-TAR cloning by our group provided
the ﬁrst method for constructing synthetic alphoid DNA arrays
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with precisely deﬁned DNA sequence variation and the possi-
bility of manipulating alphoid DNA arrays.24 This approach
involves rolling circle ampliﬁcation (RCA) of alphoid DNA
oligomers as small as a dimer followed by assembly of the ampli-
ﬁed fragments by transformation-associated recombination
(TAR) in yeast.25,26 Using the RCA-TAR method, synthetic
alphoid DNA arrays up to 140 kb have been generated and used
for de novo HAC formation.24 The method also permitted gener-
ation of a synthetic HAC with a conditional centromere, the
alphoidtetO-HAC,27 which has been instrumental in resolving a
role for chromatin structure in kinetochore function.23 The
alphoidtetO-HAC is based on a dimeric alphoid DNA array that
contains alternating monomers with either CENP-B boxes or
tetracycline operator (tetO) sequences. The latter sequences allow
speciﬁc engineering of the alphoidtetO-HAC using chromatin
modiﬁers fused to the tetracycline repressor (tetR). The
alphoidtetO-HAC has been extensively used to investigate protein
interactions within the kinetochore and to deﬁne the epigenetic
signature of centromeric chromatin to maintain a functional
kinetochore.9,23,28−33 Studies with this HAC revealed that
nucleating heterochromatin or high levels of active transcription
within centrochromatin disrupts kinetochore function27−29 and
that a low level of transcription is needed to maintain an active
kinetochore.9,33 Recent studies using the alphoidtetO-HAC
showed that histone modiﬁcations and centromeric transcription
block heterochromatin spreading into centrochromatin, thus
preventing kinetochore inactivation.33 Histone modiﬁcations
linked to transcription might act as an epigenetic barrier between
centrochromatin and pericentromeric heterochromatin.
Although heterochromatin occurs in close proximity to
centromeres, its role in chromosome segregation varies among
species. S. pombe may provide an extreme example with its depen-
dence on heterochromatin for de novo deposition of CENP-A and
for proper cohesion dynamics.34 In contrast, the role of peri-
centromeric heterochromatin on kinetochore function in humans
remains poorly understood. Results from diﬀerent groups showed
that disruption of pericentromeric heterochromatin is associated
with chromosome mis-segregation and tumorigenesis.35−37
In this work, we have constructed a new alphoidhybrid-HAC
containing two distinct synthetic alphoid arrays to investigate the
role of heterochromatin domains on kinetochore maintenance
and function. This HAC is based on a synthetic hybrid array
consisting of an alphoidtetO array linked to a novel alphoid DNA
array derived from monomeric alpha-satellite DNA lacking
CENP-B boxes and containing lac operators (lacO) and yeast
Gal4 binding sites. Transfection of the hybrid array into human
HT1080 cells resulted inHAC formation. The alphoidhybrid-HAC
was used to examine whether heterochromatin or centrochro-
matin can be induced to spread laterally by targeting chromatin
modiﬁers.
■ RESULTS AND DISCUSSION
Construction of the Hybrid tetO/lacOgal4 Synthetic
Arrays by RCA-TAR Cloning.Wewished to construct a human
artiﬁcial chromosome (HAC) containing centrochromatin and
pericentromeric heterochromatin domains (alphoidhybrid-HAC)
to manipulate the epigenetic status of both domains indepen-
dently. As the basis for the kinetochore domain, we designed a
343 bp alphoid 21-I dimer from high-order repeats (HORs) of
chromosome 21 in which sequences corresponding to the
CENP-B box in one monomer were replaced by a 42 bp tetra-
cycline operator sequence (tetO), the binding site for E. coli
tetracycline repressor (tetR) (Figure 1). As the basis for the
pericentromeric heterochromatin domain, we synthesized a
novel 2,078 bp alphoid 21-II-lacOgal4 12-mer that lacked
CENP-B boxes but contained four gal4 binding sites (each 21 bp
in size) and four lacO sequences (each 36 bp in size). These
permit targeting the heterochromatin domain with chimeric
proteins containing the yeast gal4 protein and/or E. coli lactose
repressor (lacI) (Figure 2).
HAC formation requires input naked alphoid DNA of at least
30 kb in size for functional CENP-A core assembly.38 For this
purpose, an artiﬁcial alphoid 21-I (α21-I) dimer and a synthetic
α21-II-lacOgal4 12-mer were extended by rolling circle ampli-
ﬁcation (RCA) using phage ϕ29 DNA polymerase followed by
yeast Transformation-associated recombination (TAR) cloning
(Figure 3).24,25 These steps yielded two arrays, i.e.∼ 40 kb α21-I-
tetO and ∼40 kb α21-II-lacOgal4 arrays, cloned into the 10,209
bp YAC/BAC-based RCA-Sat43 vector containing the mamma-
lian selectable marker blasticidin (Bsr)24 (Figures 3b, 4,a and 4b;
see Materials and Methods for details). The tandem repeat
structure of the α21-II-lacOgal4 array was conﬁrmed by AlwN1
Figure 1. Sequence of the alphoid dimer used for construction of the α21-I-tetO array. Both monomers are derived from a chromosome 21 alphoid
type I (HOR). Onemonomer contains a CENP-B box (shaded blue). In the secondmonomer, the position corresponding to the CENP-B box sequence
was replaced by a 42 bp tetO motif (shaded yellow).
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digestion, which revealed a 2,078 bp 12-mer (Figure 4c). The
tandem repeat structure of the α21-I-tetO array was conﬁrmed
by EcoRI digestion, which revealed a 343 bp 2-mer (Figure 4d).
To generate a hybrid array containing both α21-I-tetO and
α21-II-lacOgal4, the two arrays were combined by recombina-
tion in yeast. After screening ∼190 colonies by CHEF gel
electrophoresis, we obtained a molecule consisting of 25 kb α21-
II-lacOgal4 and 30 kb α21-I-tetO arrays in the RCA-Sat43 vector
(Figures 3c and 4e). This hybrid YAC/BAC DNA molecule of
∼65 kb in size (∼55 kb alphoid array plus ∼10 kb vector) was
moved to bacterial cells and served as the input DNA for further
HAC formation.
HAC Formation Using the Hybrid α-Satellite Array in
Human HT1080 Cells. For HACs to be obtained, the RCA-
Sat43 vector containing the hybrid array was puriﬁed from large-
scale bacterial cultures (see Materials and Methods). The quality
of the hybrid array DNA was checked by CHEF gel electro-
phoresis (data not shown). Input DNA was transfected into
human HT1080 cells, and blasticidin S (BS)-resistant clones
were selected for cytogenetic analysis. A total of 17 BS-resistant
clones were obtained and expanded after transfection of the
hybrid array DNA construct. To determine the fate of the hybrid
array in HT1080 cells (expected to be either episomal HACs or
chromosome integrations), these clones were processed for
ﬂuorescence in situ hybridization (FISH) using the RCA-Sat43
vector backbone as DNA probe directly labeled with Spectrum
Green (Abbott Molecular) (Figure 5a). FISH analyses showed
that most of the BS-resistant clones (13 out of 17; 76.5%)
contain array integrations into endogenous chromosome arms
(Figure 5b). Indeed, the most common fate of the input DNA
construct in HAC formation experiments is integration into
endogenous chromosome arms11,24,27,39 (Figure 5b). No prefer-
ential chromosomes or chromosome positions were observed for
these array integrations.
FISH analysis revealed that the hybrid array formed HACs
in 2 of 17 BS-resistant cell lines (clones 20.05 and 20.07),
showing 11 and 60% of HAC-containing metaphases, respec-
tively (Figure 5b). Clone 20.05 also showed metaphases con-
taining array integrations into endogenous chromosomes.
A third clone (clone 20.22) showed a single HAC-containing
metaphase plus 40% of metaphases containing array integrations
(Figure 5b) and was not considered as a HAC-containing cell line.
Figure 2. Sequence of the alphoid 12-mer used for construction of the α21-II-lacOgal4 array. All monomers were derived from a chromosome
21 alphoid type II array. Four gal4 sequences (two 21 bp in size and two dimers 42 bp in size; shaded green) and four lacO sequences (each 36 bp in size;
shaded red) were incorporated into a 12-mer. Fifteen MseI sites are present in the 12-mer.
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Only clones showing a minimum of 5% of metaphases with
detectable HACs (at least 2 out of the 25 metaphases analyzed)
were considered. The remaining BS-resistant clones showed
neither HACs nor array integrations in any metaphase analyzed,
suggesting that the clones may have acquired only the BSR gene.
Overall, we observed HAC formation with an eﬃciency of 11.7%
after transfection of the hybrid alphoid DNA array. This is consis-
tent with the eﬃciency observed previously by others using syn-
thetic alphoid DNA arrays for HAC formation experiments.24,27
These results showed that the hybrid array can form HACs in
human HT1080 cells with an eﬃciency similar to those of other
synthetic alphoid DNA arrays.
Figure 3. Schematic representation of construction of synthetic tandem arrays. (a) Step one includes ampliﬁcation of either a 2,078 bp 21-II-lacOgal4
12-mer or a 343 bp 21-I-tetO dimer by rolling circle ampliﬁcation (RCA) reaction up to 1−3 kb fragments. (b) Step two includes construction of long
alphoid arrays by transformation-associated recombination (TAR) cloning in yeast. The RCA-ampliﬁed fragments are cotransformed into yeast cells
along with the MluI-linearized RCA-Sat43 vector (the MluI restriction site is located between the hooks). This vector contains a BAC cassette (a BAC
replicon and a Clm marker), a YAC cassette (a selectable marker HIS3, a centromere sequence CEN6 from yeast chromosome VI, and yeast origin of
replication ARSH4), and a mammalian marker Bsr (the blasticidin gene) that allows the vector to propagate in yeast, bacterial, and mammalian cells and
alphoid-speciﬁc hooks of 40 bp each (Ebersole et al. 2005). Recombination of the RCA-ampliﬁed fragments accompanied by their recombination with
the hooks results in the rescue of long arrays as circular YAC/BACs, and 40 kb α21-I-tetO and 40 kb α21-II-lacOgal4 arrays were chosen for further
experiments. (c) Construction of the hybrid tetO-CENPB+-lacOgal4-CENPB− array. Recombination between the arrays accompanied by their
recombination with the vector hooks leads to formation of the hybrid arrays. Ultimately, a molecule containing a 20 kb lacOgal4 array and 25 kb tetO
array was chosen for HAC formation.
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CENP-A Overexpression Signiﬁcantly Increases the
Eﬃciency of HAC Formation. The low eﬃciency of de novo
HAC formation is one limitation for the wider application of
HAC technology.20,23,40 We were therefore interested when it
was recently reported that elevated levels of CENP-A increase
the frequency of centrochromatin assembly and minichromo-
some formation in S. pombe.41 Moreover, we previously observed
that seeding of centromeric chromatin at ectopic array integra-
tions under diﬀerent conditions is enhanced in cells overexpressing
CENP-A.42
To investigate the eﬀect of CENP-A levels on the eﬃciency of
de novo HAC formation, we transfected the hybrid array into
HT1080 cells transiently overexpressing CENP-A. As in previous
HAC formation experiments, BS-resistant clones were selected
and further expanded for cytogenetic analysis. FISH experiments
revealed HACs in 11 of the 23 BS-resistant clones obtained after
transfection with a range of 8−76% of HAC-containing meta-
phases (Figure 5c). Two additional clones showedHACs in a single
metaphase and therefore were not considered as HAC-positive
cell lines (Figure 5c). Some clones showed both array integrations
and HACs as previously described for other HACs.27,43 For further
analysis, we chose two clones, 20.CA.07 and 20.CA24 (Figure 5c),
that contained only autonomously replicating HACs.
Thus, transient CENP-A overexpression increases the eﬃ-
ciency of HAC formation by 3-fold (Figure 5d), overcoming an
important limitation of the HAC technology.
Figure 4. Hybrid alphoid-DNA array construction. (a) CHEF analysis of 13 BACs with α21-II-lacOgal4 arrays of diﬀerent size. The BAC DNAs were
linearized by AvaII to release a vector part and an array. BAC #12 has an array of∼40 kb in size. (b) CHEF analysis of the BAC with the α21-I-tetO array
of∼40 kb in size. The BACDNAwas digested by NheI/SpeI to release a vector fragment and the array. (c) Conﬁrmation of the tandem repeat structure
of 40 and 60 kb α21-II-lacOgal4 arrays by AlwN1 digestion. CHEF analysis revealed 2,461 bp 12-mer α21-II-lacOgal4 repeat units. (d) Conformation of
the tandem repeat structure of a 40 kb α21-I-tetO array by EcoRI digestion. CHEF analysis revealed 343 bp 2-mer 21-I-tetO repeat units. (E) CHEF
analysis of the hybrid α21-I-tetO/a21-II-lacOgal4 arrays. (Lane 1) Array consisting of 10 kb of the α21-II-lacOgal4 array and 30 kb of the a21-I-tetO
array. (Lane 2) Array consisting of 25 kb α21-II-lacOgal4 array and 30 kb α21-I-tetO array. The array in lane 2 (in red) was chosen for HAC formation.
(Lane 3) Array consisting of 15 kb α21-II-lacOgal4 array and 40 kb α21-I-tetO array.
ACS Synthetic Biology Research Article
DOI: 10.1021/acssynbio.8b00018
ACS Synth. Biol. 2018, 7, 1116−1130
1120
The Alphoidhybrid-HAC Contains Both Alphoid DNA
Arrays. Previous molecular analyses have revealed that HACs
are formed by ampliﬁcation of the input DNA that may be
accompanied by structural rearrangements, generating complex
structures containing alternating blocks of α-satellite DNA and
vector backbone.10,11,43,44 Because we used a hybrid α-satellite
array as input DNA for HAC formation, it was possible that the
resulting alphoidhybrid-HAC could have lost one of the two
original arrays as a consequence of DNA reorganization in
HT1080 cells. Therefore, we used oligo-FISH with labeled
oligonucleotides that speciﬁcally recognize the tetO, lacO, and
gal4 sequences to examine whether the HAC contains both
α-satellite arrays. Oligo-FISH was ﬁrst developed by Matera and
Ward45 to detect repetitive sequences such as speciﬁc α-satellite
DNA families. The use of small oligonucleotide probes, which
show superior hybridization kinetics, has proven to be superior
for faster and more sensitive FISH protocols. In our case, the
repetitive nature of the hybrid HAC allows the visualization of
oligonucleotide probes, as they hybridize in large numbers, thus
allowing speciﬁc detection of the two diﬀerent arrays in theHAC.
This experiment revealed that the HACs in both selected
clones (20.CA.07 and 20.CA.24) have FISH signals for tetO and
Figure 5. Hybrid HAC formation in HT1080 cells. (a) Representative FISH images of clones containing a HAC (left) and an array integration in an
endogenous chromosome (right). (b, c) Screening of blasticidin-resistant clones by FISH. Diagrams represent the frequency of metaphases with HACs
(black bars) and array integrations (gray bars) (N = 25) in HT1080 cells without (b) and with (c) CENP-A overexpression. (d) Frequency of HAC-
containing clones with (CENP-A OE) and without (CENP-A WT) transient CENP-A overexpression during HAC formation. Only clones with a
minimum of 10% metaphases containing HACs were considered as positive (10 vs 33%). (e) Representative two-color oligo-FISH images showing
diﬀerent hybrid HACs (clone 20.CA.07-top and 20.CA.24-bottom) containing tetO (red) and lacOgal4 (green) domains. Images were captured at opti-
mized exposure times to clearly distinguish both signals in either clone (for signal intensity comparison between clones, see Figure S2). (f) Repre-
sentative image of an HT1080 cell containing HAC clone 20.CA.24 and expressing both lacI-GFP (green) and tetR-mCherry (red) fusion proteins.
Merged image (right panel) represents the overlay of GFP, mCherry, and DAPI channels. (g) Frequency of HAC-containing metaphases in the indicated
clones containing HACs in the presence of blasticidin and after 30 days after blasticidin washout. The HAC loss rate is indicated in red. (h) Repre-
sentative immunoﬂuorescence images on metaphase spreads of HAC clone 20.CA.24 and stained with the indicated antibodies. Scale bars = 10 μm.
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lacO + gal4 oligonucleotide probes (Figure 5e and Figure S1a).
Therefore, the novel HACs contain both synthetic α-satellite
DNA arrays. Importantly, a control experiment using the 1C7
cell line, which contains the alphoidtetO-HAC,28 showed a signal
only for the tetO DNA array with no signal for the lacO + gal4
DNA array. This conﬁrms the speciﬁcity of the probes used for
oligo-FISH (Figure S1a).
To further conﬁrm the presence of both synthetic arrays in the
alphoidhybrid-HAC, we expressed tetR-mCherry and lacI-EGFP in
these HT1080 cell lines and then analyzed the tethering of these
fusion proteins to the hybrid HACs. As expected, the results
showed the presence of signals for both tetR-mCherry and lacI-
EGFP in interphase nuclei (Figure 5f). The signals were also
detected on the HACs in metaphase chromosome spreads, where
the HACs can be identiﬁed by DAPI staining (Figure S1b).
These data demonstrate the successful construction of novel
synthetic HACs containing both α21-I-tetO and α21-II-lacOgal4
synthetic alphoid-DNA arrays. Such alphoidhybrid-HACs rep-
resent a novel targeting system for future epigenetic engineering
studies of the centromere.
TheAlphoidhybrid-HACSegregatesAccurately duringCell
Division.Two independent clones containing alphoidhybrid-HACs
(clones 20.CA.07 and 20.CA.24) were selected for further studies.
In clone 20.CA.24, only 20% of the cells carry the alphoidhybrid-
HAC; for this reason, we subcloned this cell line by limiting dilu-
tion to obtain a homogeneous population of HAC-containing
cells. A total of 37 BS-resistant subclones were analyzed by FISH
for the presence of the alphoidhybrid-HAC. Among them, one
subclone (subclone 5B10) was shown to carry single alphoidhybrid-
HACs in 100% of the metaphases analyzed (N = 25). The other
subclones showed neither HACs nor integration in chromosome
arms, suggesting that only the bsr gene was integrated.
To analyze the mitotic stability of these HACs, we grew the
cells in the presence and absence of BS selection for 30 days
(∼30 cell divisions) and monitored the presence of HACs by
FISH. As a positive control, we included the 1C7 cell line, which
contains the previously constructed alphoidtetO-HAC.27,28 The
daily loss rate of the HAC (R) was calculated using the formula
Nn= N0 × (1 − R)n, where N0 is the number of metaphase
chromosome spreads showing HAC in the cells cultured under
selection,Nn is the number of HAC-containingmetaphase chromo-
some spreads after n days of culture in the absence of selection.
In 1C7 cells, the alphoidtetO-HAC was present in 22 out of 25
metaphases analyzed (88%) when cells were grown in the
presence of BS. In the absence of BS selection for 30 days, the
alphoidtetO-HAC was present in 20 out of 25 metaphases (80%).
Thus, the daily loss rate of the alphoidtetO-HAC was established
at 0.0032 (Figure 5g). This is consistent with the values
previously observed (0.0021−0.0054).27
The alphoidhybrid-HAC in clone 20.CA.07 showed a decrease
of HAC-containing metaphases from 76 to 72% when BS selec-
tion was removed for 30 days, and the frequency of metaphases
with the HAC in clone 20.CA.24−5B10 decreased from 96 to
80% after BS washout (Figure 5g). Thus, the daily rates of loss
observed in clones 20.CA.07 and 20.CA.24−5B10 were 0.0018
and 0.0054, respectively, showing a mitotic behavior similar to
that of the alphoidtetO-HAC. These results indicate that the
alphoidhybrid-HACs have a high mitotic stability in the absence of
selection, indicating that these HACs replicate and segregate
accurately during cell division.
The high mitotic stability observed for the alphoidhybrid-HACs
suggests that these synthetic chromosomes contain the basic ele-
ments to maintain chromosome function. To conﬁrm this, we
performed immunoﬂuorescence (IF) on unﬁxed metaphase
spreads with antibodies that recognize diﬀerent complexes that
are important for chromosome segregation (Figure 5h). IF showed
the presence of the outer kinetochore protein HEC1 on the
alphoidhybrid-HAC (Figure 5h). Other protein complexes impor-
tant for centromere function were also detected on the HAC at
levels similar to endogenous chromosomes: speciﬁcally, the
chromosome passenger complex shown by the presence of
survivin staining of the HAC, the chromosome scaﬀold compart-
ment shown by SMC2 staining of the HAC, and pericentromeric
heterochromatin shown by the presence of HP1α in the HAC
(Figure 5h). We thus conclude that the alphoidhybrid-HAC
contains a functional kinetochore resembling that of endogenous
chromosomes.
The alphoidhybrid-HAC has a high mitotic stability comparable
to the synthetic alphoidtetO-HAC described previously.27 Further-
more, the alphoidhybrid-HAC resembles natural chromosomes,
containing the basic protein complexes necessary for chromo-
some structure, function, and stability.
Structural Characterization of the Alphoidhybrid-HAC
Shows Contiguous Tandem Copies of the Input DNA.
Because the alphoidhybrid array formsmitotically stable HACs that
resemble natural chromosomes, we went on to perform cyto-
genetic and molecular biology experiments to characterize the
molecular organization of both alphoidhybrid-HAC clones. Oligo-
FISH experiments on metaphase spreads clearly showed that the
HAC in clone 20.CA.24−5B10 is larger than the HAC in clone
20.CA.07, as shown by DAPI and FISH signal intensities for both
the tetO and lacOgal4 domains (Figure S2). Importantly, these
results were conﬁrmed by expressing tetR-EYFP and lacI-mCherry
fusion proteins in HT1080 cells containing the alphoidhybrid-
HACs. Whereas the alphoidhybrid-HAC in clone 20.CA.24−5B10
showed clear signals for both fusion proteins tethered to tetO
and lacO sites, those signals were hardly visible in clone 20.CA.07
(data not shown). For this reason, we used the 20.CA.24−5B10
alphoidhybrid-HAC for further characterization. Interestingly,
although alphoidhybrid-HAC 20.CA.07 is signiﬁcantly smaller, its
mitotic stability is higher compared to those of other synthetic
HACs. Therefore, HAC size does not correlate in a simple
manner with mitotic stability.
As shown above, FISH analysis of interphase and metaphase
cells revealed the presence of lacOgal4 and tetO arrays in the
alphoidhybrid-HAC in clone 20.CA.24 (Figure 5e). We performed
high-resolution ﬁber-FISH analysis to see how the arrays are
organized in this HAC. DNA ﬁbers were prepared fromHT1080
cells containing the HAC and hybridized with either tetO-
speciﬁc or a mixture of the lacO plus gal4-speciﬁc oligonucleotide
probes46 (see Materials and Methods). Representative images
are shown in Figure 6a. This ﬁber-FISH analysis revealed
alternating blocks of α21-I-tetO and α21-II-lacOgal4 arrays. The
results are consistent with those obtained by interphase FISH
analysis of the 20.CA.07 alphoidhybrid-HAC (Figure S3a−c),
which show α21-I-tetO and α21-II-lacOgal4 blocks that are
repeated in tandem.
Structural analysis of the alphoidhybrid-HACs in both clones
was also carried out by Southern blot hybridization. Genomic
DNA containing the alphoidhybrid-HACs was digested by SpeI
endonuclease. This endonuclease cuts the vector RCA-Sat43
sequence once but does not have recognition sites in the alphoid
α21-I-tetO or α21-II-lacOgal4 DNA arrays. SpeI-digested
genomic DNA was separated by CHEF gel electrophoresis and
hybridized with two diﬀerent probes. One probe was speciﬁc to
the tetO-alphoid sequence. The other was speciﬁc for both the
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lacO and gal4 sequences (see Materials andMethods for details).
If the HACs were formed by simple concatenation involving
rolling-circle ampliﬁcation of the input DNA and had not
undergone structural rearrangements, only one band of 65 kb in
size (∼55 kb alphoid array plus ∼10 kb vector part) would be
observed on the Southern blot after SpeI digestion. For the
original clone 20.CA.24 (containing ∼25% of HAC-containing
metaphases; see Figure 5), four major bands of 95, 65, 40, and
30 kb were detected with the tetO probe, and a similar proﬁle
with two additional minor bands of 60 and 8 kb was observed
with the lacOgal4 probe (Figure 6b). For clone 20.CA.07, two
major bands of 95 and 65 kb were detected with the tetO and
lacOgal4 probes (Figure S3d).
Unexpectedly, for 20.CA.24 subclone 5B10, only one major
band of 65 kb in size was observed (∼55 kb array plus ∼10 kb
vector). These results indicate that the original clones 20.CA.24
and 20.CA.07 are likely a mixture of the cells with diﬀerent-sized
HACs. In contrast, the 5B10 subclone contains only one HAC
with a regular structure containing alternating tetO and lacOgal4.
This could suggest a rolling circle ampliﬁcation mechanism of
formation of this HAC. These results are in agreement with the
alternating organization of α21-I-tetO and α21-II-lacOgal4 DNA
blocks observed by ﬁber-FISH analysis (Figures 6a). Taking
these data together, a proposed diagram of the hybrid HAC in
subclone 5B10 is presented in Figure 6c.
Interestingly, this novel alphoidhybrid-HAC (subclone 5B10)
had much more regular structure than the original synthetic
alphoidtetO-HAC (subclone AB2.218.21).27 Southern blot
hybridization of the SpeI-digested genomic DNA harboring the
alphoidtetO-HAC revealed 15 fragments of diﬀerent size,
indicating complex rearrangements of 50 kb input alphoidtetO-
DNA array during HAC formation.43 It also contained a large
region from the long arm of chromosome 13, suggesting that at
one point during its formation it may have integrated into that
chromosome. It is possible that the more regular structure
of the alphoidhybrid-HAC may be due to a more eﬃcient process
of de novo HAC formation, possibly as a result of CENP-A
overexpression.
These results show that de novo alphoidhybrid-HAC formation
was accompanied, as expected, by ampliﬁcation of the input
DNA molecule but that ampliﬁcation can occur without gross
structural rearrangements. Future experiments will determine
whether this is due to HAC formation in the presence of
overexpressed CENP-A.
Figure 6. Structural analysis of the hybrid HAC propagated in human HT1080 cells. (a) Representative ﬁber-FISH images of clone 20.CA.24 HAC
using oligonucleotide probes for tetO (red) and lacO + gal4 sequences (green). Diﬀerent degrees of ﬁber stretching are shown (compare upper and
lower panels). (b) Genomic DNA possessing the original HAC clone 20.CA.24 (left panel) and its subclone (5B10; right panel) were digested with SpeI
endonuclease and separated by CHEF gel electrophoresis (range 10−100 kb). The SpeI recognition site is present once in the RCA-SAT43 vector at
position 812 but not in the hybrid array. The transferred membrane was hybridized with radioactively labeled tetO-speciﬁc or lacO + gal4-speciﬁc
probes. The 5B10 subclone has a HAC with a remarkably conserved array. Arrows indicate fragments of 95, 65, 40, and 30 kb in size that are speciﬁc to
both probes. (c) Diagram illustrating multimerization of input DNA during de novo HAC formation in human HT1080 cells. Input DNA consists of
65 kb hybrid array and 10,209 bp RCA-Sat43 vector sequence.
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Epigenetic Engineering Showed a Functional Two-
Domain Kinetochore in Alphoidhybrid-HAC That Can Be
Manipulated with Diﬀerent Targeting Systems. As shown
above, the alphoidhybrid-HAC in 20.CA24 subclone 5B10 is
composed of regular alternating tandem blocks of α21-I-tetO
and α21-II-lacOgal4 repeats.
We next asked where the kinetochore is localized in this HAC
using chromatin immunoprecipitation with CENP-A antibodies
followed by qPCR (ChIP-qPCR). Surprisingly, the results showed
equal amounts of CENP-A on both the α21-I-tetO and α21-II-
lacOgal4 arrays (Figure 7a). It was previously demonstrated that
CENP-B box sequences are a requisite for de novo kinetochore
nucleation.11,24 This suggested that either (i) seeding of CENP-A
chromatin on the alphoidhybrid-HAC was initiated on both con-
secutive α21-I-tetO and α21-II-lacOgal4 blocks or (ii) CENP-A
chromatin assembled ﬁrst on the α21-I-tetO domains containing
CENP-B boxes and subsequently spread to the ﬂanking α21-II-
lacOgal4 domains that lack CENP-B.
To look at the ability of proteins to spread across the two
arrays (array “cross-talk”), we transiently expressed KAP1 fused
to either tetR-EYFP or lacI-GFP in 5B10 cells. KAP1 is a
chromatin modiﬁer that disrupts the kinetochore by seeding
heterochromatin marks, including H3K9me3.28 Expression of
tetR-EYFP-KAP1 caused a signiﬁcant decrease of CENP-A levels
on the alphoidhybrid-HAC compared to that of control experi-
ments tethering tetR-EYFP (Figure 7b and c). The decrease of
CENP-A levels observed after tethering tetR-EYFP-KAP1 was
accompanied by an increase of HACmis-segregation, as revealed
by a signiﬁcantly increased frequency of cells showing an abnor-
mal number of HACs compared to controls (Figure 8c). On the
other hand, tethering lacI-GFP-KAP1 to the alphoidhybrid-HAC
did not result in signiﬁcant diﬀerences inCENP-A levels compared
to control tethering of either lacI-GFP or tetR-EYFP (Figures 7b
and c). LacI-GFP-KAP1 tethering also did not cause an increase
in HAC segregation defects, as the cells maintained a stable HAC
number (Figure 8c). These results are consistent with the
previous results using the alphoidtetO-HAC.28
This suggests that heterochromatin nucleated on the α21-II-
lacOgal4 array did not spread eﬃciently into the core centromere
domain on the α21-I-tetO array.
Recent models suggest that chromatin modiﬁcations present
at centrochromatin allow CENP-A and kinetochore assembly
and maintenance.23 In particular, chromatin modiﬁcations asso-
ciated with transcriptionally active chromatin, such as H3K4me2
and H3K9 acetylation, increase the CENP-A level and prevent
heterochromatin spreading to centrochromatin that can ulti-
mately inactivate the kinetochore.9,33 To examine the functional
interactions between centrochromatin containing CENP-A and
ﬂanking heterochromatin, the alphoidhybrid-HAC was targeted
with combinations of chromatin modiﬁers binding to the two
diﬀerent HAC domains. As a proof of principle, we simulta-
neously targeted the C-terminal transactivation domain of
Figure 7. Epigenetic engineering shows the presence of a two-domain centromere in the alphoidhybrid HAC. (a) ChIP-qPCR analysis of CENP-A levels
in HT1080 clone 5B10 containing the alphoidhybrid HAC. The α21-I-tetO (tetO), α21-II-lacOgal4 (lacOgal4) hybridHAC domains, satellite D17Z1
(Chr17), and degenerate satellite type-II (Sat2) repeats were assessed. (b) Representative images of HT1080−5B10 cells expressing the indicated tetR
and lacI-fusion proteins and stained with H3K9me3 (second panel) and CENP-A (third panel) antibodies. Merge images represent the overlay of GFP
(green), H3K9me3 (blue), and CENP-A (red). (c) Quantiﬁcation of HAC-associated CENP-A staining in individual cells transfected with the indicated
fusion proteins and plotted as A.F.U. Solid bars indicate the medians, and error bars represent the s.e.m. n = two independent experiments for each time
point and staining. Asterisks indicate a signiﬁcant diﬀerence (*P < 0.05; **P < 0.01; Mann−Whitney test). Scale bars = 10 μm.
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NF-ΚB p65 to the α21-I-tetO domains and KAP1 to the α21-II-
lacOgal4 domains as tetR-SNAP and lacI-GFP fusion proteins,
respectively. Tethering of tetR-SNAP-p65 together with lacI-GFP
signiﬁcantly increased CENP-A levels on the alphoidhybrid-HAC
compared to that of a control tethering of tetR-SNAP with lacI-
GFP (Figures 8a and b). As previously reported for the alphoidtetO-
HAC,29 tethering tetR-SNAP-p65 to the alphoidhybrid-HAC
increases levels of H3K9ac (Figure S4b). In parallel experiments,
Figure 8. Alphoidhybrid HAC shows epigenetically distinct centromeric domains. (a) Representative images of HT1080−5B10 cells expressing the
indicated tetR (ﬁrst panel) and lacI-fusion proteins (second panel) and stained with antibodies recognizing H3K9me3 (third panel) and CENP-A
(fourth panel). Merged images represent the overlay of TMR-SNAP, GFP, and H3K9me3 (MERGE 1; ﬁfth panel) and GFP, H3K9me3 and CENP-A
(MERGE 2; sixth panel). (b) Quantiﬁcation of HAC-associated CENP-A staining in individual cells transfected with the indicated fusion proteins and
plotted as A.F.U. Solid bars indicate the medians, and error bars represent the s.e.m. n = two independent experiments for each time point and staining.
Asterisks indicate a signiﬁcant diﬀerence (**P < 0.01; Mann−Whitney test). (c) Quantiﬁcation of alphoidhybrid HAC copy-numbers as determined by
counting the GFP and/or TMR-SNAP spot in interphase nuclei of cells transfected with the indicated fusion proteins. Data represent the mean
(and s.e.m.) of three independent assays of each time point after doxycycline washout (n = 1,000 nuclei per condition; *P < 0.05, **P < 0.0001; χ2-test).
(d) ChIP-qPCR analysis in HT1080−5B10 cells using the indicated antibodies. The α21-I-tetO (tetO), α21-II-lacOgal4 (lacOgal4) hybridHAC domains,
the satellite D17Z1 (Chr17), and the degenerate satellite type-II (Sat2) repeats were assessed. Scale bars = 10 μm.
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tethering lacI-GFP-KAP1 to the alphoidhybrid-HAC increased the
H3K9me3 level (Figure S4a). Simultaneous tethering of lacI-
GFP-KAP1 together with tetR-SNAP maintained the CENP-A
level similar to that observed in controls (Figure 8a and b).
Strikingly, simultaneous tethering of tetR-SNAP-p65 with lacI-
GFP-KAP1 seems to balance the levels of H3K9ac and
H3K9me3 (Figure S4), and the levels of CENP-A are maintained
similar to those observed in controls (Figure 8a and b). Thus,
although there does appear to be cross-talk between the two
domains of the HAC, kinetochore function is preserved as
demonstrated by the proper segregation of the alphoidhybrid-HAC
when these fusion proteins were tethered together (Figure 8c).
The epigenetic environment in the centromere is important
for kinetochore assembly and maintenance.23 To study the
epigenetic diﬀerences between the diﬀerent centromeric
domains in the alphoidhybrid-HAC, we performed ChIP-qPCR
experiments pulling down diﬀerent histone H3 modiﬁcations
typically associated with centromeric chromatin, such as
H3K4me2, H3K36me2, and H3K9me3 (Figure 8d). The results
showed that there is no diﬀerence in the amount of the
heterochromatin marker H3K9me3 between α21-I-tetO and
α21-II-lacOgal4 domains or between the alphoidhybrid-HAC and
the centromere of the endogenous chromosome 17 (Figure 8d).
Thus, the level of heterochromatin is similar between the
alphoidhybrid-HAC centromere and endogenous centromeres.
The lower level of H3K9me3 in the Sat2 region could be
explained by the lower level of heterochromatin in HT1080 cells
(Figure 8d).36,47
We also observed diﬀerent levels of chromatin marks
associated with actively transcribed chromatin on the α21-I-
tetO and α21-II-lacOgal4 arrays. Whereas H3K4me2 is prefer-
entially enriched on the α21-II-lacOgal4 arrays, H3K36me2 was
preferentially enriched on the α21-I-tetO arrays (Figure 8d). The
diﬀerent localizations of H3K4me2 and H3K36me2 on centro-
chromatin suggest that these histone modiﬁcations may play
diﬀerent roles in kinetochore assembly and/or maintenance.
Previous results showed that removing H3K4me2 from the
alphoidtetO-HAC centromere disrupts kinetochore maintenance
and function.33 The present results suggest that it will be
important in the future to explore the role of H3K36me2 in
centrochromatin in greater detail.
Our proof of principle experiments reveal that the
alphoidhybrid-HAC containing two synthetic domains can be
manipulated for epigenetic engineering studies. Our results with
this novel HAC reinforce the model that centromeres are
assembled and maintained by a speciﬁc chromatin environment.
Moreover, our experiments combining the opposing chromatin
modiﬁers p65 and KAP1 revealed that, although there is cross-
talk between the kinetochore and heterochromatin domains,
induced heterochromatin disrupts the centromere only when it is
nucleated within centrochromatin. Inducing heterochromatin in
the pericentromeric domains did not disrupt the kinetochore,
possibly due to the presence of speciﬁc histone modiﬁcations
and/or active RNAP II transcription at centrochromatin that
protects it from heterochromatin spreading.
■ CONCLUSIONS
We developed and characterized a novel synthetic alphoidhybrid-
HAC (human artiﬁcial chromosome) containing two distinct
alphoid DNA arrays. The two synthetic arrays can remain
remarkably preserved during HAC formation in contrast to the
gross rearrangements observed with the previous generation of
alphoidtetO HACs. The alphoidhybrid-HAC allows simultaneous
independent targeting of chromatin modiﬁers to diﬀerent
centromeric compartments using independent tetO and lacO/
gal4 targeting systems, and our preliminary experiments reveal
that there is some cross-talk between the chromatin in two arrays.
The alphoidhybrid-HAC may be used in future studies to clarify
whether the endogenous CENP-A chromatin is continuous or
interrupted with blocks of heterochromatin in natural human
chromosomes.
■ MATERIALS AND METHODS
Construction of α21-I-tetO and α21-II-lacOgal4
Alphoid Arrays by Rolling-Circle Ampliﬁcation (RCA)
Followed by Transformation-Associated Recombination
(TAR) in Yeast. Amethod to rapidly convert any desirable DNA
fragment, as small as 100 bp, into long tandem DNA arrays up to
140 kb in size is described in detail in a previous publication.48
The method includes rolling-circle phi29 ampliﬁcation (RCA) of
the sequence in vitro and assembly of the RCA products in vivo
by homologous recombination in the yeast Saccharomyces
cerevisiae. In our case, for the RCA reaction we used a 343 bp
21-I alphoid dimer from high-order repeats (HORs) of chro-
mosome 21 containing CENP-B boxes and a 2,078 bp
synthesized 21-II-lacOgal4/CENPB minus-12-mer. In one of
the monomers of the 21-I alphoid dimer, a CENP-B box was
replaced by a 42 bp tetO motif (see Figure 1). In the 21-II
alphoid 12-mer, four gal4 sequences (each 21 bp in size) and four
lacO sequences (each 36 bp in size) were incorporated
(see Figure 2). RCA reactions were performed using an
Amersham TempliPhi kit according to the manufacturer’s instruc-
tions except that reactions were scaled up to 100 μL and were
spiked with a template-speciﬁc primer mix to a ﬁnal concentration
of 2 pmol/μL (Figure 3a). Reaction products were phenol/
chloroform extracted and ethanol precipitated prior to recombi-
national cloning. As a second step, the length of the resulting
RCA products was extended by transformation-associated homol-
ogous recombination (TAR) in yeast25,26,49 using a targeting RCA-
Sat43 vector24 (Figure 3B). The RCA-Sat43 vector (10,209 bp in
size) contains YAC (HIS3, CEN6, ARSH4) and BAC (Cm, ori F)
cassettes as well as a mammalian selectablemarker (BSR). Also, the
RCA-Sat43 vector contains the appropriate alphoid satellite hooks
of ∼40 bp each. Before yeast transformation, the vector was
linearized by MluI to release targeting hooks. The highly trans-
formable Saccharomyces cerevisiae strain VL6−48N (MATalpha,
his3-Δ200, trp1-Δ1, ura3-Δ1, lys2, ade2−101, met14), which has
HIS3 and URA3 deletions, was used for transformation.
Conditions for spheroplast transformation were described
previously.50 Typically, each transformation used 2−3 μg of
RCA product and 0.02 μg of the linearized vector. Under such
conditions, 200−1000 His+ transformants were usually
obtained. As a third step, yeast transformants were combined
into pools, and then puriﬁed genomic DNA from the yeast clones
was electroporated into Escherichia coli cells (DH10B, Invitrogen).
The insert size of α21-II-lacOgal4 arrays was determined by
CHEF (Bio-Rad) afterAvaII digestion, which releases an∼6.5 kb
vector fragment and an array plus ∼3.5 kb vector fragment. Repre-
sentative CHEF analysis of 13 BACs is shown (Figure 4a). Diges-
tion of the α21-II-lacOgal4 arrays by AlwNI reveals 12-mers of
2,078 bp in size (Figure 4b). The insert size of α21-I-tetO arrays
was determined by CHEF (Bio-Rad) after NotI digestion that
releases an∼2 kb fragment of the RCA-Sat43 vector and an array
plus ∼7 kb vector fragment. Representative CHEF analysis of
one BAC is shown (Figure 4c). Digestion of the α21-I-tetO
arrays by EcoRI reveals 2-mers of 343 bp in size (Figure 4d).
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Construction of the Hybrid tetO-CENPB+/lacOgal4-
CENPB− Array by Recombinational Cloning in Yeast.
A general scheme of construction of the synthetic hybrid tetO-
CENPB+/lacOgal4-CENPB- array is presented in Figure 3c.
The∼40 kb α21-II-lacOgal4 array (Figure 4a; lane 12) and∼40 kb
α21-I-tetO array (Figure 4c) were chosen for construction of the
hybrid tetO-CENPB+/lacOgal4-CENPB− array. Restriction of
BAC DNAs was done by endonucleases that cleave the molecule
at insert/vector junctions and by an endonuclease that cuts the
vector part completely. The 40 kb α21-II-lacOgal4 array was
released by digestion with MspI/NsiI endonucleases (33 MspI
recognition sites are present in the RCA-Sat43 vector). The 40 kb
α21-I-tetO array was released by digestion withMseI/SpeI/NheI
endonucleases (57 MseI recognition sites are present in the
RCA-Sat43 vector). The α21-II-lacOgal4 and α21-I-tetO arrays
were gel-puriﬁed after CHEF separation, mixed with MluI-
digested RCA-Sat43 vector (the MluI site is present between the
hooks and not present in the arrays) and transformed into
Saccharomyces cerevisiae strain VL6−48N. Typically, 0.5 μg of
each array and 0.02 μg of the linearized RCA-Sat43 vector were
used for one transformation. Under such conditions, 100−300
His+ transformants were usually obtained. Next, genomic DNA
from yeast clones washed from plates was isolated and
electroporated into Escherichia coli cells (DH10B, Invitrogen).
Because homology between α21-II-lacOgal4 and α21-I-tetO
arrays is ∼70−74%, the percentage of the hybrid arrays was very
low, i.e., ∼0.1%. The insert size of the entire hybrid arrays in the
BACs was checked by MspI digestion. The size of the α21-I-tetO
part in the hybrid arrays was checked by MseI digestion (this
endonuclease completely digests a vector part and a α21-II-
lacOgal4 array). The size of the α21-II-lacOgal4 array in the
hybrid arrays was checked by MslI or AlwI (these endonucleases
digest a vector part and the α21-I-tetO array). A BAC containing
a hybrid array consisting of ∼25 kb α21-II-lacOgal4 array and
∼30 kb α21-I-tetO array was chosen for further HAC
development experiments (Figure 4e).
Southern Blot Hybridization Analysis. Southern blot
hybridization was performed with a 32P-labeled probe as
described previously51 with minor changes. Genomic DNA was
prepared in agarose plugs and restriction-digested by SpeI in the
buﬀer recommended by the manufacturer. The digested DNA
was CHEF (CHEF Mapper, Bio-Rad) separated (autoprogram,
5−150 kb range, 16 h transfer), transferred to membrane
(Amersham Hybond-N+), and blot-hybridized with an 82 bp
probe for tetO and a 74 bp probe for lacO and gal4. DNA
sequences for the probes were ampliﬁed by PCR using the
primers and synthetic DNA fragment as a template (tetO_-
south_21_M: 5′-TTTGTGGAAGTGGACATTTACTAGCA-
GCAGAGCTCTCCCTATCAGTGATAGAGACTAGCCCA-
TAAAAATAGACAGAAGCATT-3′, tetO_south_21_F1:
5′-TTTGTGGAAGTGGACATTTC-3′, tetO_south_21_R1:
5′-AATGCTTCTGTCTATTTTTA-3′; lacO_south3_M:
5′-TGTGGAAGTGGACATTTCGACCACATGTGGAATT-
GTGAGCGGATAACAATTTGTGGCCCATAAAAATAGA-
CAGA-3′, lacO_south3_F1: 5′-TGTGGAAGTGGACATTT-
CGA-3′, lacO_south3_R1: 5′-TCTGTCTATTTTTATGG-
GCC-3′; gal4_south1_M: 5′-AATGGACATTTCGA-
CGGAGGACAGTCCTCCGTCGACGGAGGACAGTCCT-
CCGCATAAAATCTA-3′, Gal4_south1_F1: 5′-AATGGACA-
TTTCGACG-3′, gal4_south1_R1: 5′-TAGATTTTATGCG-
GAG-3′). The blot was incubated for 2 h at 65 °C for
prehybridization in Church’s buﬀer (0.5 M Na-phosphate buﬀer
containing 7% SDS and 100 μg/mL of unlabeled salmon sperm
carrier DNA). The labeled probe was heat denatured in a boiling
water bath for 5 min and snap-cooled on ice. The probe was
added to the hybridizationChurch’s buﬀer and allowed to hybridize
for 48 h at 65 °C. Blots were washed twice in 2× SSC (300 mM
NaCl, 30 mM sodium citrate, pH 7.0), 0.05% SDS for 10 min at
room temperature, then twice in 2× SSC, 0.05% SDS for 5 min at
60 °C. Blots were exposed to X-ray ﬁlm for 5 days at −80 °C.
Cell Culture, Transfections, and HAC Formation.
HumanHT1080 cells were maintained in DMEM supplemented
with 10% FBS (Invitrogen) plus 100 U/ml penicillin G and
100 μg/mL of streptomycin sulfate (Invitrogen). Cells were
grown at 37 °C in 5%CO2 in a humidiﬁed atmosphere. Transfec-
tions were performed using Xtremegene-9 (Roche) following the
manufacturer’s instructions. In brief, for transfections of cells
growing in 10 cm dishes, transfection complexes containing 15 μL
of Xtremegene-9 reagent and 5 μg of plasmid DNA were
prepared in 500 μL of OptiMEM (Invitrogen). After 20 min of
incubation at room temperature, 500 μL of transfection
complexes was added dropwise in 10 mL of media. After 24 h,
transfected cells were selected adding 4 μg/mL of blasticidin S
(Sigma) and grown for 2−3 weeks until separate resistant colo-
nies were present. Resistant colonies were isolated by trypsinization
in cloning cylinders (Thermo Scientiﬁc). Isolated clones
were expanded in the presence of 4 μg/mL of blasticidin S.
For cotransfection experiments with the CENP-A-SNAP plasmid,
5 μg of plasmid DNA was added to the transfection reaction.
Fluorescent in Situ Hybridization (FISH). Samples were
processed as previously described by us.46 In brief, metaphase
chromosomes were obtained following standard procedures: 3 h
before harvesting, cells were treated with Colcemid (Invitrogen)
at a ﬁnal concentration of 0.2 μg/mL. They were then resus-
pended in warm hypotonic solution (0.075 M KCl) for 10 min at
37 °C and ﬁxed in methanol:acetic acid (3:1). To obtain
stretched chromatin ﬁbers, 2 mL of a cell culture was centrifuged,
and the pellets were washed in 1× PBS. Pellets were resuspended
in 1× PBS to reach a ﬁnal concentration of 2 × 106 cells/mL and
spread on slides. Once the slides were mounted on the Shandon
Sequenza cover plates (Thermo Scientiﬁc), DNA ﬁbers were
released applying a lysis solution (0.07 MNaOH in ethanol) and
ﬁxed in methanol. Slides were kept at −20 °C until they were
processed for FISH.
The RCA-Sat43 vector backbone was used as DNA probe.
BAC DNA extraction was performed using the EndoFree
Plasmid Maxi kit (Qiagen GmBh; Hilden, Germany) following
the manufacturer’s instructions. BAC DNA was labeled by Nick
translation using Spectrum Green dUTPs (Abbott Molecular)
following the manufacturer’s instructions. Probes were mixed
with 10 μg of Cot 1 DNA (Invitrogen; Carlsbad, USA), ethanol
precipitated, and resuspended in 1× hybridization buﬀer (50%
formamide, 1× SSC, and 10% dextran sulfate) to a ﬁnal
concentration of 40 ng/μL. For oligo-FISH experiments,
oligonucleotides recognizing the tetO sequence (5′- ACTAG-
CAGCAGAGCTCTCCCTATCAGTGATAGAGACTAG-3′)
labeled with Digoxigenin, and oligonucleotides recognizing both
lacO (5′- CATGTGGAATTGTGAGCGGATAACAATTTG-
TGG-3′) and Gal4 (5′- TCGACGGAGGACAGTCCTCCG-3′)
sequences labeled with Biotin were synthesized (Sigma).
Oligonucleotides were mixed at 100 ng/ μL and resuspended
in 2× hybridization buﬀer (Cellay Inc.), 10× blocking reagent
(Cellay Inc.), and 50 μg/mL of salmon sperm DNA (Sigma).
FISH was carried out following standard procedures.46 Brieﬂy,
the DNA probe was denatured at 80 °C for 5 min and
preannealed at 37 °C for 30 min. Slides were denatured in
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70% formamide/2× SSC at 70 °C for 1 min and hybridized in a
humid chamber at 37 °C overnight. Slides were washed in
0.7×SSC/0.03%NP40 for 1 min at 70 °C and in 2×SSC/0.03%
NP40 for 2 min at room temperature. For Oligo-FISH experi-
ments, slides were denatured in 70% formamide/2×SSC at 70 °C
for 1 min and hybridized in a humid chamber at 37 °C for 2 h.
Slides were thereafter washed in 20%formamide/2×SSC for
5 min and in 2×SSC/0.1%Tween-20 for 5 min at 37 °C.
Oligonucleotide probes were detected with rhodamine-con-
jugated antidigoxigenin (Roche) and ﬂuorescein-conjugated
streptavidin (Vector Laboratories). Slides were mounted with
Vectashield (Vector Laboratories) containing 4′,6-diamidino-2-
phenylindole (DAPI) for chromosome counterstaining.
Indirect Immunoﬂuorescence Staining and Micros-
copy. Indirect immunoﬂuorescence staining of cells ﬁxed in
4% formaldehyde/1×PBS was performed following standard
procedures. Immunoﬂuorescence on unﬁxed metaphase spreads
was performed as described previously.9 The following antibod-
ies were used: mouse anti-CENP-A (clone A1, 1:500), mouse
anti-HP1α (Millipore MAB3584, 1:1000), mouse anti-HEC1
(abcam AC3612, 1:1000), rabbit anti-SMC2 (A. Losada, 1:1000),
rabbit anti-Survivin (Cell Signaling, 1:400), rabbit anti-H3K9me3
(abcam 8898; 1:200), and rabbit anti-H3K9ac (B. Turner,
1:200).
Microscope images were acquired on a DeltaVision Core
system (Applied Precision) using an Olympus IX-71 inverted
microscope stand with an Olympus UPlanSApo 100× oil immer-
sion objective (numerical aperture (NA) 1.4) and an LED light
source. Camera (Photometrics Cool Snap HQ), shutter, and
stage were controlled through SoftWorx (Applied Precision).
Z-series were collected with a spacing of 0.2 μm, and image stacks
were subsequently deconvolved in SoftWorx. For CENP-A signal
quantiﬁcation, a custom-made macro in ImageJ (National Insti-
tutes of Health, Bethesda, MD) modiﬁed from Bodor et al.52
was used.
Chromatin Immunoprecipitation and Quantitative
PCR (ChIP-qPCR). Exponentially growing cells were washed
in D-PBS (Gibco) and subsequently harvested with TrypLE
Express (Gibco). Cells were resuspended inD-PBS up to a concen-
tration of 1 × 106 cells/ml and cross-linked in a ﬁnal 1% form-
aldehide solution (Sigma) for 5 min at room temperature,
followed by quenching with 2.5 M glycine for 5 min at room
temperature. Cells at a concentration of 5 × 106 cells/ml were
lysed in lysis buﬀer (10 mM Tris pH 8.0; 10 mM NaCl;
0.5% NP-40) containing protease inhibitors (1 μg/mL of CLAP;
0.5 μg/mL of Aprotinin; 1 mM PMSF) for 10 min on ice. Nuclei
were brieﬂy washed in lysis buﬀer with protease inhibitors in
300 μL of dilution buﬀer 1 (50 mM Tris pH 8.0; 2 mM EDTA;
0.2% SDS; 134 mM NaCl; 0.88% Triton X-100; 0.088%
Na-deoxycholate). Chromatin was sheared by sonication in a
Bioruptor sonicator (Diagenode) for 14 cycles (30s ON/30S
OFF) at high setting and 4 °C. Supernatant products of
sonication were diluted with 300 μL of dilution buﬀer 1, 500 μL
of dilution buﬀer 2 (50 mM Tris pH 8.0; 167 mM NaCl; 1.1%
Triton X-100; 0.11% Na-deoxycholate), and 500 μL of RIPA
buﬀer containing 150 μL of NaCl (RIPA-150) and protease
inhibitors. Antimouse IgG Dynabeads (Invitrogen) were coated
with the relevant antibodies for 6 h with RIPA-150/0.5% BSA at
4 °C and washed twice with RIPA-150/0.5% BSA, and 500 μL of
sheared chromatin was incubated with the beads at 4 °C
overnight. Beads were afterward washed twice with RIPA-150
and RIPA buﬀer containing 500 mM NaCl (RIPA-500) and a
ﬁnal wash with TE pH 8.0. Antibody/chromatin complexes were
de-cross-linked with 10% Chelex-100 resin (BioRad) in water at
93 °C and treated with RNase A and Proteinase K. DNA was
subsequently recovered by aliquoting 60 μL of the supernatant in
a new eppendorf tube. ChIPed DNA was subjected to RT-PCR
using a SYBR Green Master Mix (Roche) using the following
oligonucleotides: tetO-Fw (5′-CCACTCCCTATCAGTGATA-
GAGAA-3′), tetO-Rv (5′-TCGACTTCTGTTTAGTTCTGT-
GCG-3′) for the α21-I-tetO domain of the hybrid HAC,
lacOgal4-Fw (5′-TATGGTGTCGACGGAGGACA-3′), and
lacOgal4-Rv (5′-CCGCTCACAATTCCACATGTG-3′) for
the α21-II-lacOgal4 domain of the hybrid HAC, chr17-Fw
(5′-TTGTGGTTTGTGGTGGAAAA-3′) and chr17-Rv
(5′-CTCAAAGCGCTCCAAATCTC-3′) for the alphoidchr17
array, bsr-Fw (5′-CAGGAGAAATCATTTCGGCAGTAC-3′)
and bsr-Rv (5′-TCCATTCGAAACTGCACTACCA-3′) for the
blasticidin resistance gene, sat2-Fw (5′-TCGCATAGAATCG-
AATGGAA-3′) and sat2-Rv (5′-GCATTCGAGTCCGTGGA-3′)
for the pericentromeric alphoidchr1, act-Fw (5′-GCCGGGACC-
TGACTGACTAC-3′) and act-Rv (5′-AGGCTGGAAGAGTG-
CCTCAG-3′) for actin.
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